SCOPUS 정보 검색 플랫폼

Volumn 118, Issue 17, 2002, Pages 641-644

Induction therapy with interferon alfa-2a in compensated hepatitis C virus-related cirrhosis. Randomized, multicenter study

(13) Planas, Ramon a Quer, Juan Carlos b Enríquez, Jaime c Barrera, Joseph Maria d Dalmau, Blai e Casanova, Teresa f Viver, Joseph Maria g Torres, Miquel h Boadas, Jaume i Solà, Ricart j Duránder, Rosa a Richart, Cristóbal b Bruguera, Miquel d

a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL (Spain)

b HOSPITAL UNIVERSITARI JOAN XXIII (Spain)

c HOSPITAL DE LA SANTA CREU I SANT PAU (Spain)

d HOSPITAL CLÍNIC (Spain)

e HOSPITAL DE SABADELL (Spain)

f L'Hospitalet de Llobregat (Spain)

g HOSPITAL MÚTUA DE TERRASSA (Spain)

h Santa Coloma de Gramenet (Spain)

i HOSPITAL DE TERRASSA (Spain)

more..

Author keywords

Cirrhosis; Hepatitis C virus; Interferon alpha

Indexed keywords

ALPHA2A INTERFERON; ANTIVIRUS AGENT;

ADULT; ARTICLE; ASCITES; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; OUTCOMES RESEARCH; SIDE EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEPATITIS C; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VIROLOGY;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0037062276 PISSN: 00257753 EISSN: None Source Type: Journal
DOI: 10.1016/S0025-7753(02)72483-4 Document Type: Article

Times cited : (8)

References (26)

1
- 0030928695
- Hepatitis C: The clinical spectrum of the disease
- (1997) Hepatology , vol.26 , pp. 15-20
- Hoofnagle, J.H.¹

2
- 0030933395
- Natural history of liver fibrosis progression in patients with chronic hepatitis C
- for the OBS-VIR, METAVIR and DOSVIR groups
- (1997) Lancet , vol.349 , pp. 825-832
- Poynard, T.¹ Bedossa, P.² Opolon, P.³

3
- 0031959794
- Hepatitis C: Somber views of natural history and optimistic views of interferon treatment
- (1998) Hepatology , vol.27 , pp. 1443-1444
- Poynard, T.¹ Opolon, P.²

4
- 0030931156
- Hepatitis C and hepatocellular carcinoma
- (1997) Hepatology , vol.26 , pp. 30-38
- Di Bisceglie, A.¹

5
- 0030955347
- Therapy of hepatitis C: Patients with cirrhosis
- (1997) Hepatology , vol.26 , pp. 128-132
- Schalm, S.¹ Fattovich, G.² Brouwer, J.T.³

6
- 0009732959
- Long-term course and prognostic factors in hepatitis C virus-related compensated cirrhosis
- (1998) J. Hepatol , vol.28 , pp. 80
- Farmachidi, J.P.¹ Rufat, P.² Vilgrain, V.³ Njapoum, C.⁴ Valla, D.⁵ Marcellin, P.⁶

7
- 0009701824
- Conferencias de Consenso: Tratamiento con interferón en las hepatitis crónica
- (1994) Med. Clin. (Barc) , vol.103 , pp. 498-504

8
- 0009733456
- Coinfección con el virus de la hepatitis G en la hepatitis crónica C. Respuesta al tratamiento con interferón alfa
- (2000) Med. Clin. (Barc) , vol.114 , pp. 735-736
- Quintero, D.¹ Salmerón, J.² Palacios, A.³ Muñoz de Rueda, P.⁴ Torres, C.⁵ Rodríguez, L.⁶

9
- 0028876371
- Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
- (1995) Lancet , vol.346 , pp. 1051-1055
- Nishiguchi, S.¹ Kuroki, T.² Nakatani, S.³ Morimoto, H.⁴ Takeda, T.⁵ Nakajima, S.⁶

10
- 0032997086
- Treatment of hepatitis C virus-related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment
- (1999) Hepatology , vol.29 , pp. 1870-1875
- Valla, D.-C.¹ Chevallier, M.² Marcellin, P.³ Payen, J.-L.⁴ Trepo, C.⁵ Fonck, M.⁶

11
- 0032560376
- Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study
- International Interferon-alpha hepatocellular carcinoma study group
- (1998) Lancet , vol.351 , pp. 1535-1539

12
- 0033520109
- Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and non-cirrhotic patients with chronic hepatitis C in Japan
- for the IHIT Study Group
- (1999) Ann. Intern. Med , vol.131 , pp. 174-181
- Yoshida, H.¹ Shiratori, Y.² Moriyama, M.³ Arakawa, Y.⁴ Ide, T.⁵ Sata, M.⁶

13
- 0025203837
- Clinical pharmacokinetics of interferons
- (1990) Clin. Pharmacokinet , vol.19 , pp. 390-399
- Wills, R.J.¹

14
- 0030039045
- Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
- (1996) Hepatology , vol.23 , pp. 366-371
- Zeuzem, S.¹ Schmidt, J.M.² Lee, J.-H.³ Rüster, B.⁴ Roth, W.K.⁵

15
- 0031009603
- Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
- (1997) Hepatology , vol.26 , pp. 226-231
- Lam, N.P.¹ Neumann, A.U.² Gretch, D.R.³ Wiley, T.E.⁴ Perelson, A.S.⁵ Layden, T.J.⁶

16
- 0031308570
- Treatment of cirrhotic hepatitis C virus patients with daily doses of interferon-α2a
- (1997) J. Viral. Hepat , vol.4 , pp. 75-78
- Cooksley, W.G.E.¹ Dudley, F.J.² Watson, K.³

17
- 0034619946
- Peginterferon alfa-2a in patients with chronic hepatitis C
- (2000) N. Engl. J. Med , vol.343 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, V.² Raenack, J.³ Heathcote, E.J.⁴ Lai, M.-Y.⁵ Gane, E.⁶

18
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N. Engl. J. Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶

19
- 0030885469
- Factors predictive of a beneficial response to therapy of chronic hepatitis C
- (1997) Hepatology , vol.26 , pp. 122-127
- Davis, G.L.¹ Lau, J.Y.N.²

20
- 0035061788
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: An evidence-based approach
- (2001) J. Hepatol , vol.34 , pp. 593-602
- Cammà, C.¹ Giunta, M.² Andreone, P.³ Craxi, A.⁴

21
- 12644299637
- Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C
- (1997) Hepatology , vol.26 , pp. 780-785
- Shiffman, M.L.¹ Hofmann, C.M.² Thompson, E.B.³ Ferreira-González, A.⁴ Contos, M.J.⁵ Koshy, A.⁶

22
- 0034619980
- Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
- (2000) N. Engl. J. Med , vol.343 , pp. 1673-1680
- Heathcote, E.J.¹ Shiffman, M.L.² Cooksley, W.G.E.³ Dusheiko, G.M.⁴ Lee, S.S.⁵ Balart, L.⁶

23
- 0032547944
- Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
- (1998) N. Engl. J. Med , vol.339 , pp. 1493-1499
- Davis, G.L.¹ Esteban-Mur, R.² Rustgi, V.³ Hoefs, J.⁴ Gordon, S.C.⁵ Trepo, C.⁶

24
- 17844403232
- A randomised, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
- (2001) Hepatology , vol.34 , pp. 395-403
- Lindsay, K.L.¹ Trepo, C.² Heintges, T.³ Shiffman, M.L.⁴ Gordon, S.C.⁵ Hoefs, J.C.⁶

25
- 0035934568
- Peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
- (2001) Lancet , vol.358 , pp. 958-965
- Manns, M.P.¹ McHutchison, J.G.² Gordon, S.C.³ Rustgi, V.K.⁴ Shiffman, M.L.⁵ Reindollar, R.⁶

26
- 0000268538
- Pegylated (40kDa) interferon alfa-2a (PEGASYS) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study
- (2001) Gastroenterology , vol.120 , pp. A55
- Fried, M.W.¹ Shiffman, M.L.² Reddy, R.K.³ Smith, C.⁴ Marino, G.⁵ Goncales, F.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.